Reply to comment on 'An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers' by Fukui et al

Breast Cancer. 2024 Mar 4. doi: 10.1007/s12282-024-01552-y. Online ahead of print.NO ABSTRACTPMID:38433180 | DOI:10.1007/s12282-024-01552-y

Source: Breast Cancer - March 3, 2024 Category: Cancer & Oncology Authors: Reiko Fukui Takahiro Watanabe Koji Morimoto Yukie Fujimoto Masayuki Nagahashi Eri Ishikawa Seiichi Hirota Yasuo Miyoshi Source Type: research